IDBS and Scitara form strategic partnership

By The Science Advisory Board staff writers

June 8, 2021 -- Biopharmaceutical lifecycle management technology provider IDBS and Scitara have inked a strategic partnership agreement.

Under the deal, Scitara's Digital Lab Exchange (DLX) platform will be integrated with IDBS' Polar pharmaceutical lifecycle management software platform, according to the companies.

Designed to address the challenge of sharing and digitalizing laboratory data across the biopharmaceutical lifecycle, the combined package will enable IDBS customers to gain connectivity to any instrument or application in regulated and nonregulated laboratories, the firms said.

Scitara raises $5M to develop its DLX platform
Scitara has raised $5 million in series A financing that it plans to use to fully develop its Digital Lab Exchange (DLX) platform.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter